Stay updated on RMC-6291 Monotherapy in KRASG12C Mutant Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the RMC-6291 Monotherapy in KRASG12C Mutant Solid Tumors Clinical Trial page.

Latest updates to the RMC-6291 Monotherapy in KRASG12C Mutant Solid Tumors Clinical Trial page
- Check3 days agoChange DetectedVersion 23 (dated 2026-05-12) adds a new 'Study Status' entry to the Record History. This update records the trial's current status as part of the historical log.SummaryDifference0.4%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check25 days agoChange DetectedThis updates the displayed interface revision/version of the ClinicalTrials.gov record history page from v3.5.0 to v3.5.3 without changing the underlying study information.SummaryDifference0.1%

- Check39 days agoChange DetectedEligibility and Study Status sections were added to the record on 2026-04-08. A related update occurred on 2026-04-06, and a prior version was removed on 2024-11-07.SummaryDifference0.4%

- Check60 days agoChange DetectedRevision v3.5.0 has been added to the history. Revision v3.4.3 has been removed from the history.SummaryDifference0.1%

- Check75 days agoChange Detected- Added revision entry v3.4.3 to the record history, replacing v3.4.2.SummaryDifference0.1%

- Check96 days agoChange DetectedAdded Revision: v3.4.2 and removed Revision: v3.4.1 from the page history.SummaryDifference0.1%

Stay in the know with updates to RMC-6291 Monotherapy in KRASG12C Mutant Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RMC-6291 Monotherapy in KRASG12C Mutant Solid Tumors Clinical Trial page.